GW Pharmaceuticals PLC is a biopharmaceutical company focused on the development and commercialization of novel therapeutics from its proprietary cannabinoid product platform. Currently, the company’s primary product offering is Sativex®, which is approved for the treatment of spasticity related to multiple sclerosis in 27 countries outside of the United States. To increase market share, the […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.